EVOK - Evoke Eversana to launch telehealth solution for Gimoti
- Evoke Pharma ( NASDAQ: EVOK ) and Eversana are launching a telehealth solution to improve patient access to Gimoti.
- Gimoti is used to relieve symptoms of slow stomach emptying in adults with diabetes.
- The new direct-to-patient technology solution will use Eversana's partnership with UpScriptHealth, a direct-to-consumer telehealth platform. Evoke said in an Aug. 16 press release.
- "This partnership with EVERSANA and UpScriptHealth provides another key channel through which we may meaningfully improve patient access to GIMOTI," said Evoke's Chief Business Officer Matt D’Onofrio.
For further details see:
Evoke, Eversana to launch telehealth solution for Gimoti